BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//talks.cam.ac.uk//v3//EN
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
CATEGORIES:Department of Pharmacology Seminar Series
SUMMARY:Engineering insights into the strange world of can
 cer - Dr Shiladitya Sengupta\, Harvard Medical Sch
 ool\, US
DTSTART;TZID=Europe/London:20221028T123000
DTEND;TZID=Europe/London:20221028T013000
UID:TALK184922AThttp://talks.cam.ac.uk
URL:http://talks.cam.ac.uk/talk/index/184922
DESCRIPTION:Bio: Dr. Shiladitya Sengupta is an associate profe
 ssor of medicine at Harvard Medical School and lea
 ds the center for engineered therapeutics at the M
 ass General-Brigham Hospital. His laboratory use t
 ools from nanotechnology and bioengineering to exp
 lore biological phenomenon at unique scales and to
  design new therapeutics. For example\, he develop
 ed the first layer-by-layer nanoparticle that allo
 ws targeting different components of a tumor on a 
 temporal scale (Nature). Recently\, his lab discov
 ered a new mechanism of tumor immune evasion\, whe
 re the cancer cells harvest immune cell mitochondr
 ia through nanoscale tentacles (Nature Nanotechnol
 ogy).  He holds over 50 pending/granted patents\, 
 and many of his inventions/research have led to st
 art-ups\, which have raised over $300M in R&D fund
 ing. Over 100 students and postdoctoral fellows ha
 ve trained in his laboratory\, have won multiple b
 est paper awards and fellowships\, and have gone o
 n to successful careers in academia and in the bio
 tech industry. He has received the TR35 Top 35 Glo
 bal Innovators award from MIT Technology Review ma
 gazine\, the Era of Hope scholar award\, and the S
 cholar and Innovator award (with Erkki Ruoslahti a
 nd Roger Tsien) from US Department of Defense\, et
 c. He completed his undergraduate education at the
  All India Institute of Medical Sciences\, New Del
 hi\, his PhD in Pharmacology as a Nehru and Cheven
 ing scholar from Trinity College\, Cambridge Unive
 rsity\, and his fellowship in biological engineeri
 ng at Massachusetts Institute of Technology\, befo
 re joining Harvard as faculty.
LOCATION:https://us06web.zoom.us/j/84909272851?pwd=MWh4VTFZ
 d3ovRjN3LzZ4eU9yOVdpUT09
CONTACT:Paul Miller
END:VEVENT
END:VCALENDAR